Verge HealthTech Fund

What is Verge HealthTech Fund?

Verge HealthTech Fund is an early-stage venture capital firm based in Singapore, specializing in investments within the HealthTech and Fitness, Medical Devices and Hospital Services industries, with a keen interest in startups catering to women's health. With a minimum investment threshold of $500,000 and a maximum of $2,000,000, they target the earliest stages of company development, including pre-seed and seed rounds.

The firm is dedicated to funding innovative companies that develop technology-centric solutions designed to expand access, improve quality, and enhance the efficiency of healthcare services in emerging markets. Their investment strategy places them at the forefront of the fastest growing subsector within healthcare, focusing on transformative technologies that significantly improve healthcare delivery. The portfolio of Verge HealthTech Fund includes companies like CareLoop Health, Prosoma, Hello Inside, BrainCapture, Nostra:Biome, and Sooma Medical, which are representative of their commitment to advancing healthcare technologies globally.

They have impacted over 68+ million lives through their investments in digital healthcare platforms, diagnostics, medical devices, and digital therapeutics addressing conditions such as serious mental illness, gut health, and metabolic health for women. They believe in the power of digital health to ensure better treatment adherence, effective diagnostics, and innovate neurological monitoring solutions. Verge HealthTech Fund also engages with their network through news updates and invites startups to pitch their ideas, demonstrating their proactive approach to identifying and nurturing potential in the HealthTech space.

What they say:

We invest in technology-centric solutions that expand access, quality and efficiency to healthcare across emerging markets.